Search results
Results from the WOW.Com Content Network
[21] [22] [23] The epidemic began with the overprescription and abuse of prescription drugs. [24] However, as prescription drugs became less accessible in 2016 in response to CDC opioid prescribing guidelines, [25] there was an increase in demand and accessibility to cheaper, illicit alternatives to opioids such as heroin and fentanyl. [26]
“By requiring drug manufacturers to notify FDA when demand for a drug is surging, pharmacies and health systems can more quickly prepare for a potential shortage Improved communication between ...
With the increase in volume, the potency of opioids also increased. By 2002, one in six drug users were being prescribed drugs more powerful than morphine; by 2012, the ratio had doubled to one in three. [18] The most commonly prescribed opioids have been oxycodone and hydrocodone. The epidemic has been described as a "uniquely American problem ...
Prescription drug overuse or non-medical prescription drug use is the use of prescription medications that is more than the prescribed amount, regardless of whether the original medical reason to take the drug is legitimate. [1] [2] A prescription drug is a drug substance prescribed by a doctor and intended to for individual use only. [3]
Driving down the cost of prescription drugs has been a priority of every recent president and using Medicare’s considerable power to achieve savings has more specifically been the goal of Democrats.
Drug store chains are struggling because of falling reimbursement rates for prescription drugs, according to analysts who cover the industry. The majority of drugstores’ sales comes from filling ...
Nearly half of all 3,100 counties in America have no doctors certified to prescribe buprenorphine by the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Administration, according to a Huffington Post analysis. Hundreds of counties have very few certified doctors.
After nearly six months of negotiations and several court rulings, Medicare and drugmakers agreed on new prices for 10 popular drugs, potentially saving users $1.5 billion in out-of-pocket costs.